Meant Review
Semaglutide & tirzepatide GLP-1 weight-loss telehealth · Independently scored 7.3/10
Best for: compounded semaglutide or tirzepatide with free care coaching and a price that holds as your dose rises
Meant scores highest on the strength of its clinical program: drug options and dosing support.
Semaglutide
Tirzepatide
What the monthly price covers
Medication
Included
Provider visits
Included
Shipping
Included
Lab work
Not disclosed
Coaching
Included
No insurance needed · Vetted by our editors
Meant is a telehealth weight-loss program that offers compounded semaglutide (injection or oral), compounded tirzepatide, lower-dose microdose plans and brand Ozempic and Zepbound, with care through OpenLoop Health clinicians. Every plan includes free 1:1 care coaching and shipping, and prepay plans add a supplement kit. Compounded semaglutide starts at $179 a month, tirzepatide at $269 and microdose plans at $169.
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
Vetted alternatives to Meant
Ro
Best for: FDA-approved brand GLP-1s, including the Wegovy pill and Foundayo, with insurance help
Editorial score · methodology
Collective
Best for: the lowest flat medication price if you can absorb an annual membership fee
Editorial score · methodology
CoreAge Rx
Best for: lowest-price compounded semaglutide and tirzepatide with one flat price at every dose
Editorial score · methodology
Meant at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Semaglutide, Tirzepatide, Zepbound
- Starting price
- $179/mo (“starting at” price)
- Pricing model
- Flat: dose increases don't raise the monthly price
- What's included
- Medication · Consult · Shipping · Coaching
- FDA status
- No FDA warning letter on record
How we scored Meant
Each dimension is scored algorithmically from Meant’s published pricing, drugs offered, verification status, and disclosed inclusions, using the same six-dimension framework we apply to every provider.
Value25%
7.6/10At $179/mo (“starting at” price), Meant runs in line with the $185 median for GLP-1 providers (each program's lowest listed ongoing monthly price for compounded semaglutide). Pricing is flat across doses, so there is no escalation markup as you titrate up.
Effectiveness25%
8.2/10Meant offers both semaglutide and tirzepatide, the two GLP-1 molecules with the strongest published weight-loss trial outcomes. FDA-approved brand options are available alongside compounded versions. An oral/needle-free option is offered for patients who avoid injections.
User Experience15%
7.1/10Online intake and platform experience (consult included in the price); 8 platform features disclosed.
Trust & Safety15%
7.0/10Core details confirmed by our editors; no FDA warning letters on file.
Accessibility10%
5.8/10Meant's exact state footprint isn't published. Confirm coverage in your state before signing up.
Support10%
6.9/10Coaching/dietitian access included.
Each checked against the provider’s own site.
Providers that don’t post pricing up front score lower on Value and carry a cost-transparency note in their review. Read the full methodology →
How we verified this Meant review
Last checked November 2026- Confirmed current pricing across 7 dose/plan tiers
- Confirmed what the monthly price does and doesn't include
- Checked the FDA warning-letter database for enforcement actions
- Walked the public intake/checkout flow on the provider's site
Pricing, availability, and compliance facts come from the provider's own site and primary regulatory records. See the sources below. Editorial confidence in this data: medium.
What we checked
- Provider's own pricing page
- $169–$1,399/mo across 7 dose/plan tiers (checked November 2026)
- State pharmacy licensing & LegitScript status
- LegitScript Verified
- FDA warning-letter register
- No letter on file for this provider
What to expect when you sign up with Meant
We walked Meant’s public signup flow in November 2026 to document the process (the steps, pricing transparency, and what’s required) before you commit. (We don’t create accounts, enter medical information, or check out; this is the observable funnel, not a prescribing outcome.)
- 1'Get Started' on the site opens a short quiz that asks your weight-loss goal and what has held you back
- 2The quiz then asks for your email to continue to the full health assessment
- 3Product buttons go straight to the intake run by OpenLoop Health, which opens on a 'Security Check' robot test
- 4Meant says a clinician reviews the assessment, usually within one business day, and you are charged only if treatment is approved
- Each product page shows a 'from' monthly price before you start, but not the plan lengths or what each plan charges up front
- The FAQ says the supplement kit grows with plan length (3, 6 or 12 months) and that monthly plans don't include it
- Meant says your price stays the same for the plan even if your dose goes up
- The homepage money-back promise covers canceling before your medication ships; the refund policy page doesn't include that
- Cancellation is by email or in your account, at least 72 hours before the billing date
Meant customer support
- Phone
- 1-512-879-9187
- support@meant.health
- Hours
- Contact form replies within one business day; the site advertises 24/7 member support
GLP-1 medications Meant offers
Tap any medication to read our plain-English guide: how it works, dosing, side effects, and what the trials found.
Pricing
Prices re-verified
Weekly injection 'from $179/mo'; Meant says your price stays the same when your dose goes up during the plan.
Daily tablet 'from $209/mo'.
Weekly injection 'from $269/mo'; Meant says your price stays the same when your dose goes up during the plan.
Lower, clinician-set dose 'from $169/mo'.
Lower, clinician-set dose 'from $169/mo'.
Listed at $1299/mo; Meant says you can use insurance or pay directly and will see your exact cost before you are charged.
Listed at $1399/mo; Meant says you can use insurance or pay directly and will see your exact cost before you are charged.
Ready to get started?
Plans and promotions change often, so check Meant's current pricing and active discounts before you decide.
What we like
- Shows a LegitScript seal served by LegitScript itself
- Names its four partner pharmacies, with addresses, in its terms
- Your plan price stays the same when your dose goes up
- Free 1:1 care coaching every two weeks, plus free shipping
- No charge until a clinician approves treatment, and a full refund if you're found ineligible
- Support by phone, email and a contact form
- Brand Ozempic and Zepbound are also offered, with insurance or cash pay
Watch-outs
- Prices are 'from' figures; plan lengths and up-front totals appear only after the intake
- The homepage promises a full refund if you cancel before your medication ships, but the written refund policy gives none on cancellation
- The supplement kit comes only with prepay plans, not monthly plans
- You must cancel at least 72 hours before your billing date or you're charged for another cycle
- Its terms and refund policy list their effective date as 'Pending'
- The semaglutide microdose page calls it a dual-action GLP-1 and GIP injection, which describes tirzepatide
- Brand Ozempic at $1,299 and Zepbound at $1,399 a month are high cash prices
- Disputes go to binding arbitration, with a class action waiver
Is Meant worth it?
Meant built its program around one core idea: compounded semaglutide or tirzepatide with free care coaching and a price that holds as your dose rises. It runs $179/month (“starting at” price) at every dose; there's no clean category median to weigh that against, but it's a published number rather than one you find out only after signing up. Its standout is a needle-free oral option for people who would rather not inject.
It offers a microdosing option. It also is LegitScript-certified and charges the same price at every dose.
How much Meant costs
Compounded semaglutide runs $179–$209/month depending on plan, the low end a “starting at” price, compounded tirzepatide runs $269/month (“starting at” price), brand-name semaglutide runs $1,299/month (entry-tier price), and brand-name tirzepatide runs $1,399/month (entry-tier price).
Because Meant's headline figure is a “starting at” price, we don't set it against the roughly $185 market median for this category. That median is each program's lowest listed ongoing monthly price for compounded semaglutide, so compare Meant with the month-to-month prices of the alternatives below instead.
MadeMed (about $179/month) is one of the closest alternatives to weigh Meant against.
Medications: what Meant prescribes
Meant prescribes semaglutide (the active drug in Wegovy and Ozempic) and tirzepatide (the active drug in Zepbound and Mounjaro), the two molecules with the strongest published weight-loss trial outcomes. Pick the brand-name pen for the FDA-approved product, or the compounded version to cut the monthly cost, with the trade-off that a compounded drug isn't FDA-approved as a finished formulation.
Meant's needle-free oral option appeals if you've been avoiding a GLP-1 because of injections. Just set expectations on the science: oral, sublingual and buccal delivery of these peptides is far less studied than the injectable versions the trials used. Treat it as a convenience option, not a proven equal to the shot.
Who Meant is best for, and who should skip it
A good fit if you…
- are needle-averse and want a non-injectable option, since the oral route skips the weekly injection most GLP-1 programs require.
- want coaching and follow-up built into the price already, instead of sold separately as an upsell.
Look elsewhere if you…
- need to bill insurance, since like most of this market it's cash-pay with no claims filed on your behalf.
Trust, safety, and medical oversight
We found no FDA warning letter on file for it, though a clean record isn't the same as an endorsement, so read the rest of this review for the full picture. As with any compounded program, the most important step you can take is confirming which licensed pharmacy fills your prescription and what's in the formulation, and we explain how in our scoring methodology.
Bottom line
Meant is a reasonable telehealth GLP-1 option; weigh its pricing and coverage against the alternatives below before deciding.
The Bottom Line
Meant scores highest on the strength of its clinical program: drug options and dosing support.
Ready to start with Meant?
From $179/mo (“starting at” price). See current pricing and start your free consultation.
Head-to-head
Compare Meant vs…
Meant scores7.3/10
Side-by-side pricing, medications and scores. Pick a matchup.
Meant vs Amazon One Medical
Amazon One Medical scores 8.5/10

Meant vs Vytora Health
Vytora Health scores 8.4/10
Scores are our independent editorial ratings out of 10.
Frequently Asked Questions
Key terms, explained
New to GLP-1s? Tap any term for a quick, plain-English definition.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
The primary regulatory filings and peer-reviewed studies cited throughout this Meant review:
Sources & methodology (as of November 2026)
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
See Meant's current pricing
Plans from $179/mo (“starting at” price). Start your free consultation to check eligibility and today's price.